What Iambic Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 1 |
| Sells | 0 | 0 |
| Total trades | 18 | 18 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 11,644,734 | 11,644,734 |
| Disposed | 0 | 0 |
| Net activity | +11,644,734 | +11,644,734 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Vogelstein R Jacob | Director | Oct 16 | Derivative Conversion · C | +742,546 | — | — | 742,546 |
| Vogelstein R Jacob | Director | Oct 16 | Derivative Conversion · C | +1,458,290 | — | — | 1,458,290 |
| Vogelstein R Jacob | Director | Oct 16 | Derivative Conversion · C | +1,995,749 | — | — | 1,995,749 |
| Rastetter William H | Director | Oct 16 | Derivative Conversion · C | +8,341 | — | — | 200,920 |
| Rastetter William H | Director | Oct 16 | Derivative Conversion · C | +192,579 | — | — | 192,579 |
| Rachlin Evan Lockwood | Director | Oct 16 | Derivative Conversion · C | +57,754 | — | — | 57,754 |
| Rachlin Evan Lockwood | Director | Oct 16 | Open-market buy · P | +718,750 | $16.00 | +$11.5M | 2,588,248 |
| Rachlin Evan Lockwood | Director | Oct 16 | Derivative Conversion · C | +410,762 | — | — | 1,869,498 |
| Rachlin Evan Lockwood | Director | Oct 16 | Derivative Conversion · C | +1,458,736 | — | — | 1,458,736 |
| Secora Michael | CFO & Chief Corp Dev Ofcr | Oct 16 | Derivative Conversion · C | +61,342 | — | — | 279,902 |
| Catalio Capital Management, Lp | 10% owner | Oct 16 | Derivative Conversion · C | +742,546 | — | — | 742,546 |
| Catalio Capital Management, Lp | 10% owner | Oct 16 | Derivative Conversion · C | +1,458,290 | — | — | 1,458,290 |
| Catalio Capital Management, Lp | 10% owner | Oct 16 | Derivative Conversion · C | +1,995,749 | — | — | 1,995,749 |
| Miller Thomas F. | Chief Executive Officer | Oct 14 | Grant / award · A | +132,200 | — | — | 1,410,756 |
| Secora Michael | CFO & Chief Corp Dev Ofcr | Oct 14 | Grant / award · A | +28,400 | — | — | 218,560 |
| Olson Peter A | Chief Scientific Officer | Oct 14 | Grant / award · A | +19,500 | — | — | 30,909 |
| Manby Frederick R | Chief Technology Officer | Oct 14 | Grant / award · A | +132,200 | — | — | 1,862,665 |
| Josephson Neil | Chief Medical Officer | Oct 14 | Grant / award · A | +31,000 | — | — | 71,459 |
Loading...
